Lisa LaVange, director of the Office of Biostatistics in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, has been elected the 113th president of the ASA. LaVange will serve a one-year term as president-elect beginning January 1, 2017. Her term as president becomes effective January 1, 2018. The ASA membership also elected G. David Williamson, senior science adviser at the U.S. Centers for Disease Control and Prevention, as an ASA vice president.
Members also elected several new board members, plus officers for each of the ASA’s 27 sections.
ASA election
2017 ASA Board of Directors Candidates
The ASA announces the selection of candidates for the 2016 election. The winning candidates’ terms will begin in 2017. Make sure to look for your ballots in your email inbox and vote early.
ASA Board of Directors Candidates
The ASA announces the selection of candidates for the 2013 election. The winning candidates’ terms will begin in 2014. Make sure to look for your ballots in your email inbox and to vote early.